{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:47Z","timestamp":1787026727153,"version":"build-2736575974"},"reference-count":67,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.01446","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T18:17:33Z","timestamp":1452709053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["High Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in Cyprus"],"prefix":"10.3389","volume":"6","author":[{"given":"Leon","family":"Cantas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Suer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Imir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections.","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.3390\/ijerph10126235","article-title":"Escherichia coli in Europe: an overview.","volume":"10","author":"Allocati","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"15","key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-015-0059-2","article-title":"Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.","volume":"4","author":"Ansari","year":"2015","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijantimicag.2013.02.022","article-title":"Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004\u20132010.","volume":"41","author":"Balode","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases.","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended spectrum \u03b2eta-lactamases in the 21st century: characterization, epidemiology and the detection of this important resistance threat.","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1099\/mic.0.27849-0","article-title":"Phage therapy: the Escherichia coli experience.","volume":"151","author":"Br\u00fcssow","year":"2005","journal-title":"Microbiology"},{"issue":"71","key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-7-71","article-title":"The culturable intestinal microbiota of triploid and diploid juvenile Atlantic salmon (Salmo salar) \u2013 a comparison of composition and drug resistance.","volume":"7","author":"Cantas","year":"2011","journal-title":"BMC Vet. Res."},{"issue":"96","key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00096","article-title":"A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota.","volume":"4","author":"Cantas","year":"2013","journal-title":"Front. Microbiol."},{"issue":"144","key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2014.00144","article-title":"Review: the important bacterial zoonoses in \u201cOne Health\u201d concept.","volume":"2","author":"Cantas","year":"2014","journal-title":"Front. Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","article-title":"Prevalence and spread of extended- spectrum beta-lactamase-producing Enterobacteriaceae in Europe.","volume":"14","author":"Cant\u00f3n","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11255-015-1018-9","article-title":"Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.","volume":"47","author":"Cho","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","article-title":"Risk factors for the development of extended-spectrum B-lactamase-producing bacteria in nonhospitalized patients.","volume":"23","author":"Colodner","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"19044","key":"B14","article-title":"Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe.","volume":"13","author":"Coque","year":"2008","journal-title":"Euro Surveill."},{"key":"B15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.02.007","article-title":"Bacterial expression and antibiotic activities of recombinant variants of human beta-defensins on pathogenic bacteria and M. tuberculosis.","volume":"89","author":"Corrales-Garcia","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"B16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infection in the United States.","volume":"56","author":"Doi","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1139\/m95-002","article-title":"Lytic infection of Escherichia coli biofilms by bacteriophage T4.","volume":"41","author":"Doolittle","year":"1995","journal-title":"Can. J. Microbiol."},{"key":"B18","author":"ECDC","year":"2014","journal-title":"Antimicrobial Resistance Surveillance in Europe 2014."},{"key":"B19","author":"ESAC","year":"2009","journal-title":"European Surveillance of Antimicrobial Consumption."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10096-009-0805-6","article-title":"Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy.","volume":"28","author":"Estebanez","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B21","author":"European Centre for Disease Prevention and Control [ECDPC]","year":"2012","journal-title":"Antimicrobial Resistance Surveillance in Europe 2011."},{"key":"B22","first-page":"12","article-title":"The frequency of extended spectrum beta lactamase (ESBL) in Escherichia coli and Klebsiella pneumoniae: a report from Mashhad, Iran.","volume":"1","author":"Fatemeh","year":"2012","journal-title":"J. Med. Bacteriol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1128\/AAC.02509-14","article-title":"Pharmacological study of Cefoxitin as an alternative antibiotic therapy to Carbapenems in treatment of urinary tract infections due to Extended-Spectrum-\u03b2- Lactamase-Producing Escherichia coli.","volume":"58","author":"Guet-Revillet","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","first-page":"417","article-title":"An update on newer \u03b2-lactamase.","volume":"126","author":"Gupta","year":"2007","journal-title":"Indian J. Med. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11096-006-9006-x","article-title":"Sales of systemic anti-infective agents in Cyprus in comparison with four other European countries.","volume":"28","author":"Hadjimichael","year":"2006","journal-title":"Pharm. World Sci."},{"issue":"9","key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-9","article-title":"Bacteriophages and their implications on future biotechnology: a review.","volume":"9","author":"Haq","year":"2012","journal-title":"Virol. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2672.2012.05338.x","article-title":"Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.","volume":"113","author":"Hassan","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1469-0691.2007.01855.x","article-title":"Prevalence and clonality of extended-spectrum beta-lactamases in Asia.","volume":"14","author":"Hawkey","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1086\/429239","article-title":"Risk factors for increasing multidrug resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella species.","volume":"40","author":"Hyle","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1128\/JCM.06002-11","article-title":"Epidemiology and risk factors of community onset infections caused by Extended-Spectrum \u03b2-Lactamase-producing Escherichia coli Strains.","volume":"50","author":"Kang","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"238","key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00238","article-title":"Phage therapy: concept to cure.","volume":"3","author":"Keen","year":"2012","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended- spectrum \u03b2lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","first-page":"123","article-title":"\u201cBeta-lactamases, and resistance to beta-lactam antibiotics,\u201d in","author":"Kotra","year":"2002","journal-title":"Bacterial Resistance to Antimicrobials"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit. Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tibtech.2010.08.001","article-title":"Bacteriophages as potential new therapeutics to replace or supplement antibiotics.","volume":"28","author":"Kutateladze","year":"2010","journal-title":"Trends Biotechnol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.crvi.2005.09.010","article-title":"In situ measurements of viral particles diffusion inside mucoid biofilms.","volume":"328","author":"Lacroix-Gueu","year":"2005","journal-title":"C. R. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jinf.2008.09.034","article-title":"Community-onset extended-spectrum \u03b2- lactamase (ESBL) producing Escherichia coli: importance of international travel.","volume":"57","author":"Laupland","year":"2008","journal-title":"J. Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/00365540903470655","article-title":"Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.","volume":"42","author":"Lindb\u00e4ck","year":"2010","journal-title":"Scand. J. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/AEM.02804-12","article-title":"Synthetic peptides antimicrobial activity prediction using decision tree model.","volume":"79","author":"Lira","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0924-8579(07)70189-9","article-title":"The zeitgeist of resistance.","volume":"60","author":"Livermore","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/jac\/dki239","article-title":"CTX-M: changing the face of ESBLs in the UK.","volume":"56","author":"Livermore","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1469-0691.2007.01858.x","article-title":"Orthodox and unorthodox clavulanate combinations against extended-spectrum B-lactamase producers.","volume":"14","author":"Livermore","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","article-title":"Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia\u2013 Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).","volume":"40","author":"Lu","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mib.2011.07.028","article-title":"The next generation of bacteriophage therapy.","volume":"14","author":"Lu","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1128\/AAC.00602-12","article-title":"Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.","volume":"56","author":"Maura","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jac\/dkn489","article-title":"Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women.","volume":"63","author":"McMurdo","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijantimicag.2007.09.008","article-title":"Prevalence of extended-spectrum betalactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran.","volume":"31","author":"Mehrgan","year":"2008","journal-title":"Int. J. Antimicrob. Agent"},{"key":"B48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejim.2011.06.016","article-title":"An observational study on bloodstream extended\u2013 spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.","volume":"23","author":"Nasa","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"B49","author":"NORM\/NORM-VET","year":"2013","journal-title":"Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway."},{"key":"B50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jac\/dkq298","article-title":"Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.","volume":"65","author":"Pallett","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update.","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/0974-7796.130536","article-title":"Extended-spectrum beta-lactamase\u2013 positive Escherichia coli causing complicated upper urinary tract infection: urologist should act in time.","volume":"6","author":"Picozzi","year":"2014","journal-title":"Urol. Ann."},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0974-7796.106962","article-title":"Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population?","volume":"5","author":"Picozzi","year":"2013","journal-title":"Urol. Ann."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1128\/AAC.01519-08","article-title":"Oral and parenteral therapeutic options for outpatient urinary infections caused by Enterobacteriaceae producing CTX-M extended-spectrum \u03b2-lactamases.","volume":"53","author":"Prakash","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","first-page":"265","article-title":"Phage Therapy: a modern tool to control bacterial infections.","volume":"28","author":"Qadir","year":"2015","journal-title":"Pak. J. Pharm. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/AAC.06233-11","article-title":"Cefoxitin as an alternative to Carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-Type Extended-Spectrum \u03b2-Lactamase.","volume":"56","author":"Rapha\u00ebl","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","article-title":"Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.","volume":"34","author":"Rice","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/JCM.42.3.1089-1094.2004","article-title":"Epidemiology and clinical features of infections caused by extended-spectrum B-lactamase producing Escherichia coli in non- hospitalized patients.","volume":"42","author":"Rodr\u00edguez-Ba\u00f1o","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.17305\/bjbms.2011.2588","article-title":"Antimicrobial resistance status and prevalence rates of extended spectrum beta-lactamase producers isolated from a mixed human population.","volume":"11","author":"Ruth","year":"2011","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"863945","key":"B60","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/863945","article-title":"Bacteriophages and their role in food safety.","volume":"2012","author":"Sillankorva","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0732-8893(00)00161-9","article-title":"Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.","volume":"38","author":"Steward","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00467-009-1431-3","article-title":"Risk factors in community acquired urinary tract infections caused by ESBL-producing bacteria in children.","volume":"25","author":"Topaloglu","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1128\/JVI.02374-12","article-title":"Complete genome sequence of the novel Escherichia coli phage phAPEC8.","volume":"86","author":"Tsonos","year":"2012","journal-title":"J. Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2165\/00002512-200522100-00001","article-title":"Asymptomatic bacteriuria in elderly patients: signi?cance and implications for treatment.","volume":"22","author":"Wagenlehner","year":"2005","journal-title":"Drugs Aging"},{"key":"B65","first-page":"15","article-title":"Current concepts in urinary tract infections.","volume":"56","author":"Williams","year":"2004","journal-title":"Minerva Urol. Nephrol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/jac\/dkh424","article-title":"Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum \u03b2-lactamases in the UK.","volume":"54","author":"Woodford","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria.","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T12:00:40Z","timestamp":1567512040000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.01446\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":67,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.01446","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}